Publications

Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD

Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.

[o.262] The angioedema quality of life questionnaire (AE-QoL) – assessment of sensitivity to change and minimal clinically important difference (8)
[o.364] Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change (6)
[o.392] Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticaria (6)
[r.128] Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema (4)
[r.099] Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema (4)
[o.400] Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study (4)
[o.261] Effect of omalizumab on angioedema in H1-antihistamine resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (3)
[o.377] Pruritus and sleep disturbances in patients with psoriasis (2)
[o.362] Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) (2)
[o.322] The urticaria activity score – validity, reliability, and responsiveness (2)
[o.318] Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU (2)
[r.104] Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen (2)
[o.298] Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data (2)
[o.274] H1-antihistamine-refractory chronic spontaneous urticaria: It’s worse than we thought – first results of the multicenter real-life AWARE study (2)
[o.426] Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study (2)
[o.296] Development and validation of the cholinergic urticaria quality of life questionnaire: CholU-QoL (1)
[o.231] Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years (1)
[o.168] The German version of ItchyQoL: validation and initial clinical findings (0)
[o.172] Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria (0)
[o.351] Antihistamine‐resistant chronic spontaneous urticaria: 1‐year data from the AWARE study (0)

(Last update: 09.2024)

Number of original publications in peer-reviewed journals:	626
Number of reviews in peer-reviewed journals:	221
Number of publications (original work and reviews) in peer-reviewed journals:	847
Cumulative IF for original publications in peer-reviewed journals:	4432.59
Cumulative IF for reviews in peer-reviewed journals:	1648.22
Cumulative IF of publications (original work & reviews) in peer-reviewed journals:	6080.81
Total number of citations: 38,608, h-index: 99 (Web of Science September 2024)	38,608

Download-Information

To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.